Platinum-resistant Ovarian Cancer

Also known as: Platinum drug resistant Ovarian cancer / Platinum-resistant Ovarian Cancer (PROC) / Platinum Resistant Ovarian Cancer

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB00997Doxorubicin1Enrolling by Invitation1
DB00997Doxorubicin1Recruiting1
DB16479Inbakicept1Not Yet Recruiting1
DB16235Mirvetuximab1Active Not Recruiting1
DB16235Mirvetuximab1Enrolling by Invitation1
DB12489Mirvetuximab soravtansine1Active Not Recruiting1
DB12489Mirvetuximab soravtansine1Enrolling by Invitation1
DB01204Mitoxantrone1Terminated1
DB15721Natural Killer Cell1Not Yet Recruiting1
DB17237PHI-1011Recruiting1
DB09037Pembrolizumab1Recruiting1
DB12332Rucaparib1Active Not Recruiting1
DB17519TILT-1231Recruiting1
DB17248Adegramotide1 / 2Completed1
DB13906Aloe vera leaf1 / 2Completed1
DB18028Azenosertib1 / 2Recruiting1
DB17323CRS-2071 / 2Terminated1
DB14707Cemiplimab1 / 2Recruiting1
DB00515Cisplatin1 / 2Terminated1
DB14322Coconut oil1 / 2Completed1
DB11717Epacadostat1 / 2Terminated1
DB00441Gemcitabine1 / 2Recruiting1
DB08818Hyaluronic acid1 / 2Completed1
DB17570Ifebemtinib1 / 2Recruiting1
DB17324Listeria monocytogenes1 / 2Terminated1
DB17249Nelatimotide1 / 2Completed1
DB11793Niraparib1 / 2Recruiting1
DB09035Nivolumab1 / 2Completed1
DB15175Ofranergene obadenovec1 / 2Completed1
DB01229Paclitaxel1 / 2Completed1
DB14769Pamiparib1 / 2Recruiting1
DB09037Pembrolizumab1 / 2Completed1
DB09037Pembrolizumab1 / 2Recruiting1
DB09037Pembrolizumab1 / 2Terminated1
DB12257Platinum1 / 2Terminated1
DB12008Prexasertib1 / 2Recruiting1
DB01839Propylene glycol1 / 2Completed1
DB15073Ribose1 / 2Recruiting1
DB14272Rosemary1 / 2Completed1
DB15106Surufatinib1 / 2Recruiting1
DB00853Temozolomide1 / 2Terminated1
DB00135Tyrosine1 / 2Recruiting1
DB11648Afuresertib2Active Not Recruiting1
DB17450Albumin-stabilized nanoparticle (130 nm)2Recruiting1
DB11885Anlotinib2Unknown Status1
DB11885Anlotinib2Withdrawn1
DB00112Bevacizumab2Recruiting2
DB00441Gemcitabine2Active Not Recruiting1
DB17563Luveltamab tazevibulin2Recruiting1
DB11793Niraparib2Unknown Status1
DB01229Paclitaxel2Active Not Recruiting1
DB01229Paclitaxel2Recruiting1
DB00019Pegfilgrastim2Recruiting1
DB01030Topotecan2Withdrawn1
DB18457Zilovertamab vedotin2Completed1
DB12596Combretastatin2 / 3Terminated1
DB12577Fosbretabulin2 / 3Terminated1
DB17522Batiraxcept3Terminated1
DB00112Bevacizumab3Recruiting1
DB00515Cisplatin3Recruiting1
DB01248Docetaxel3Recruiting1
DB00997Doxorubicin3Active Not Recruiting1
DB00997Doxorubicin3Recruiting1
DB00441Gemcitabine3Active Not Recruiting1
DB00441Gemcitabine3Recruiting1
DB18187Nemvaleukin alfa3Active Not Recruiting1
DB16268Olvimulogene nanivacirepvec3Recruiting1
DB01229Paclitaxel3Active Not Recruiting1
DB01229Paclitaxel3Recruiting1
DB01229Paclitaxel3Terminated1
DB09037Pembrolizumab3Active Not Recruiting1
DB12257Platinum3Recruiting1
DB01030Topotecan3Active Not Recruiting1